Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • epistatic
    Senior Member
    • Mar 2009
    • 129

    500 million reads needed for RNA-Seq?!

    Genome Res. 2011 May 2. [Epub ahead of print]
    RNA-sequence analysis of human B-cells.
    Toung JM, Morley M, Li M, Cheung VG.
    Source
    Genomics and Computational Biology Program, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA;
    Abstract
    RNA-sequencing (RNA-seq) allows quantitative measurement of expression levels of genes and their transcripts. In this study, we sequenced complementary DNA fragments of cultured human B-cells and obtained 879 million 50-bp reads comprising 44 Gb of sequence. The results allowed us to study the gene expression profile of B-cells and to determine experimental parameters for sequencing-based expression studies. We identified 20,766 genes and 67,453 of their alternatively spliced transcripts. More than 90% of the genes with multiple exons are alternatively spliced; for most genes, one isoform is predominantly expressed. We found that while chromosomes differ in gene density, the percentage of transcribed genes in each chromosome is less variable. In addition, genes involved in related biological processes are expressed at more similar levels than genes with different functions. Besides characterizing gene expression, we also used the data to investigate the effect of sequencing depth on gene expression measurements. While 100 million reads are sufficient to detect most expressed genes and transcripts, about 500 million reads are needed to measure accurately their expression levels. We provide examples in which deep sequencing is needed to determine the relative abundance of genes and their isoforms. With data from 20 individuals and about 40 million sequence reads per sample, we uncovered only 21 alternatively spliced, multi-exon genes that are not in databases; this result suggests that at this sequence coverage, we can detect most of the known genes. Results from this project are available on the UCSC Genome Browser to allow readers to study the expression and structure of genes in human B-cells.

    PMID: 21536721 [PubMed - as supplied by publisher]
  • kopi-o
    Senior Member
    • Feb 2008
    • 319

    #2
    Sounds scary, doesn't it? Anthony Fejes commented on this paper on his blog:

    Comment

    • Richard Finney
      Senior Member
      • Feb 2009
      • 701

      #3
      From the paper: Our data are available as the ‘‘B-Cell Transcriptome
      (RNA-seq)’’ track on the UCSC Genome Browser.


      Anybody know where this is? What's the track label? What's the build?

      I looked but did not find it. Maybe it's not there yet or it's under a different track label.

      Comment

      • hungrysokoke
        Junior Member
        • Oct 2011
        • 2

        #4
        I couldn't find the B-Cell Trancriptome track on the UCSC browser either. Maybe we should email the authors to ask?

        Comment

        • Richard Finney
          Senior Member
          • Feb 2009
          • 701

          #5
          Upenn_bcell_ng_rna

          It's at cgwb.nci.nih.gov under the hg19 tracks ; I got impatient and aligned the sra reads using a "gene,alt-splice/est" model and posted it under UPENN_BCELL_NG_RNA , near bottom. I figure somebody needed to make hg19 rna-seq data publicly available and use-able.

          Try this URL :


          You view the reads using bambino here :
          Last edited by Richard Finney; 06-04-2012, 10:17 AM. Reason: correct URL

          Comment

          • hungrysokoke
            Junior Member
            • Oct 2011
            • 2

            #6
            Thank you, Dr. Finney!

            Comment

            • Richard Finney
              Senior Member
              • Feb 2009
              • 701

              #7
              No prob. Lemme know how I can improve the track (like auto-normalize, right now it's not normalized between samples).

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                07-20-2026, 11:48 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM
              • SEQadmin2
                Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                by SEQadmin2



                Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                07-08-2026, 05:17 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 07-24-2026, 12:17 PM
              0 responses
              19 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-23-2026, 11:41 AM
              0 responses
              18 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-20-2026, 11:10 AM
              0 responses
              25 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-13-2026, 10:26 AM
              0 responses
              38 views
              0 reactions
              Last Post SEQadmin2  
              Working...